AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca alliance revenue ($M) ($M)
Form 6-K / Form 20-F Alliance Revenue Breakdown Table
Latest, Q2 2026
874
Period ended Jun 30, 2026
Change on a year earlier
+33.6%
654 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up alliance revenue ($m)
- Enhertu (Daiichi Sankyo alliance) revenue ($M)550 · Q2 2026
- Tezspire (Amgen alliance) revenue ($M)218 · Q2 2026
- Beyfortus (Sanofi / Sobi alliance) revenue ($M)32 · Q2 2026
- Datroway (Daiichi Sankyo alliance) revenue ($M)51 · Q2 2026
- Other royalty income ($M)22 · Q2 2026
- Other alliance revenue ($M)1 · Q2 2026
Cite this data
StockData. (2026). AstraZeneca Alliance revenue ($M) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rev_alliance_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.